UK markets closed

Immix Biopharma, Inc. (IMMX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.1900-0.0200 (-0.90%)
At close: 04:00PM EDT
2.2016 +0.01 (+0.53%)
After hours: 06:10PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
8,735
8,735
4,196
126.527
248.149
Selling general and administrative
7,406
7,406
4,023
1,225
205.703
Total operating expenses
16,141
16,141
8,219
1,352
453.852
Operating income or loss
-16,141
-16,141
-8,219
-1,352
-453.852
Interest expense
0
0
0.497
179.853
101.976
Total other income/expenses net
-
-
-
-22,846
-574.488
Income before tax
-15,569
-15,569
-8,219
-24,378
-1,130
Income tax expense
26.415
26.415
10.268
6.013
17.547
Income from continuing operations
-15,596
-15,596
-8,230
-24,384
-1,148
Net income
-15,426
-15,426
-8,230
-24,384
-1,148
Net income available to common shareholders
-15,426
-15,426
-8,230
-24,384
-1,148
Basic EPS
-0.92
-
-0.59
-6.64
-0.13
Diluted EPS
-0.92
-
-0.59
-6.64
-0.13
Basic average shares
15,374
-
13,887
3,673
8,775
Diluted average shares
15,374
-
13,887
3,673
8,775